Merck: FDA reviewing tablet to eliminate allergy

March 27, 2013 by The Associated Press

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.

The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the U.S. to getting a long series of uncomfortable shots. Both methods work by gradually desensitizing the patient's immune system to the substance triggering the allergic reaction.

Merck's immunotherapy, still unnamed, would be taken daily throughout allergy season for three years.

The company, which is based in Whitehouse Station, N.J., also recently applied to the Food and Drug Administration for approval to sell an immunotherapy tablet for ragweed pollen.

Explore further: 'Apple allergy': Symptoms could be significantly reduced with apple-allergen treatment

shares

Related Stories

'Apple allergy': Symptoms could be significantly reduced with apple-allergen treatment

October 19, 2012
The food allergy associated with birch pollen is a condition commonly found alongside an allergy to birch pollen. Sufferers are plagued by swelling and reddening or itching in the mouth and throat area, for example when they ...

Life saving treatment for fire ant allergy under used

March 4, 2013
Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma ...

The year 2040: Double the pollen, double the allergy suffering?

November 9, 2012
With this year's unseasonably warm temperatures and extended seasons, many have coined 2012 as being the worst for allergies. But if you thought your symptoms were worse than ever, just wait until the year 2040.

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.